Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MY-REPT in Primary Liver Transplantation
NCT01766518Phase 4Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Nov 2009
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in Liver transplant rejection, sponsored by Chong Kun Dang Holdings. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT01766518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766518.